Angiotensin II-stimulated secretion of arginine vasopressin is inhibited by atrial natriuretic peptide in humans

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 300, Issue 3, 2011, Pages

  Matsukawa, Toshiyoshi ^a,b   Miyamoto, Takenori ^a  

^a Department of Neurology   (Japan)

^b Department of Psychiatry   (Japan)

Author keywords

Atrial natriuretic peptide; Baroreceptor reflex; Blood pressure; Vasopressin

Indexed keywords

ANGIOTENSIN II; ARGIPRESSIN; ATRIAL NATRIURETIC FACTOR; NITROPRUSSIDE SODIUM;

ADULT; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BLOOD SAMPLING; BODY FLUID; CENTRAL VENOUS PRESSURE; CIRCULATION; COMPETITIVE INHIBITION; CONTROLLED STUDY; HOMEOSTASIS; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; HUMAN EXPERIMENT; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; NORMAL HUMAN; PLASMA OSMOLALITY; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; SYMPATHETIC BLOCKING;

ADULT; ANGIOTENSIN II; ATRIAL NATRIURETIC FACTOR; BAROREFLEX; BLOOD PRESSURE; CENTRAL VENOUS PRESSURE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; NEUROPHYSINS; NITROPRUSSIDE; OSMOLAR CONCENTRATION; PROTEIN PRECURSORS; SINGLE-BLIND METHOD; TIME FACTORS; VASODILATOR AGENTS; VASOPRESSINS;

EID: 79954518238     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00324.2010     Document Type: Article

References (32)

1. Allen MJ, Ang VTY, Bennett ED, Jenkins JS. Atrial natriuretic peptide inhibits osmolarity-induced arginine vasopressin release in man. Clin Sci 75: 35-39, 1988.
2. Brooks VL, Keil LC, Reid IA. Role of rennin-angiotensin system in the control of vasopressin secretion in conscious dogs. Circ Res 58: 829-838, 1986.
3. Casto R, Keiler I, Schroeder G, Stock G. Angiotensin II-induced vasopressin release is attenuated by central atrial natriuretic factor. Clin Exp Hypertens A 9: 81-94, 1987.
4. 1 receptor subtype in normal men. Metabolism 47: 893-896, 1998.
5. Chiodera P, Volpi R, Pilla S, Capretti L, Coiro V. Effect of aging on the arginine-vasopressin response to physostigmine and angiotensin II in normal men. J Investig Med 48: 203-206, 2000.
6. Crandall ME, Gregg CM. In vitro evidence for an inhibitory effect of atrial natriuretic peptide on vasopressin release. Neuroendocrinolgy 44: 439-445, 1986.
7. Dusterdieck G, McElwee G. Estimation of angiotensin II concentration in human plasma by radioimmunoassay, some applications to physiological and clinical states. Eur J Clin Invest 2: 32-38, 1971.
8. Fujio N, Ohashi M, Nawata M, Kato K, Ibayashi H, Kangawa K, Matsuo H. α-Human atrial natriuretic polypeptide reduces the plasma arginine vasopressin concentration in human subjects. Clin Endocrinol 25: 181-187, 1986.
9. Ganong WF. Hypothalamic regulation of hormonal functions. In: Ganong's Review of Physiology (23rd ed.), edited by Barret KE, Barman SM, Boitano S, and Brooks HL. New York: McGraw-Hill, 2010, p. 273-287.
10. Ganong WF. Regulation of extracellular fluid composition and volume. In: Ganong's Review of Physiology (23rd ed.), edited by Barret KE, Barman SM, Boitano S, and Brooks HL. New York: McGraw-Hill, 2010, p. 665-678.
11. Gardiner SM, Bennet T. Endogenous vasopressin and baroreflex mechanisms. Brain Res Rev 11: 317-334, 1986.
12. Goetz KL. Physiology and pathophysiology of atrial peptides. Am J Physiol Endocrinol Metab 254: E1-E15, 1988.
13. Goldsmith Dodge SR, D, Pentel P. Effects of infused norepinephrine and angiotensin-II on vasopressin levels in humans. Am J Med Sci 295: 513-516, 1988.
14. Hammer M, Ølgaard K, Madsen S. The ability of angiotensin II infusions to raise plasma vasopressin levels in haemodialysis patients. Acta Endocrinol 95: 422-426, 1980.
15. Hirata Y, Ishii M, Sugimoto T, Matsuoka H, Fukui K, Yamakado M, Tagawa H, Miyata A, Kangawa K, Matsuo H. The hormonal and renal effects of atrial natriuretic peptide in patients with secondary hypertension. Circulation 78: 1401-1410, 1988.
16. Imaizumi T, Takeshita A, Higashi H, Nakamura M. α-ANP alters reflex control of lumbar and renal sympathetic nerve activity and heart rate. Am J Physiol Heart Circ Physiol 253: H1136-H1140, 1987.
17. Kimura T, Matsui K, Ota K, Yoshinaga K. Radioimmunoassay of arginine vasopressin in human plasma and urine, a resin microcolumn method. Tohoku J Exp Med 131: 37-46, 1980.
18. Matsukawa T, Gotoh E, Minamisawa K, Kihara M, Shionoiri H, Ishii M. Effects of intravenous infusions of angiotensin II on muscle sympathetic nerve activity in humans. Am J Physiol Regul Integr Comp Physiol 261: R691-R696, 1991.
19. Matsukawa T, Mano T. Atrial natriuretic hormone inhibits angiotensin II-stimulated sympathetic nerve activity in humans. Am J Physiol Regul Integr Comp Physiol 271: R464-R471, 1996.
20. Padfield PL, Morton JJ. Effect of angiotensin II on arginine vasopressin in physiological and pathological situations in man. J Endocrinol 74: 251-259, 1977.
21. Petrie MC, McDonald JE, Hillier C, Morton JJ, McMurray JJV. Effects of adrenomedullin on angiotensin II stimulated atrial natriuretic peptide and arginine vasopressin secretion in healthy humans. Br J Clin Pharmacol 52: 165-168, 2001.
22. Phillips MI. Angiotensin in the brain. Neuroendocrinology 25: 354-377, 1978.
23. Ramsay DJ. Effects of circulating angiotensin II on the brain. In: Frontiers in Neuroendocrinology, edited by Ganong WF and Martini L. New York: Raven, 1982, vol. 7, p. 263-285.
24. Samson WK. Atrial natriuretic factor inhibits dehydration and hemorrhage-induced vasopressin release. Neuroendocrinology 40: 227-279, 1985.
25. Samson WK, Aguila MC, Martinovic J, Antunes-Rodrigues J, Norris M. Hypothalamic action of atrial natriuretic factor to inhibit vasopressin secretion. Peptides 8: 449-454, 1987.
26. Samson WK. Central nervous system actions of atrial natriuretic factor. Brain Res Bull 20: 831-837, 1988.
27. Schrier RW, Berl T, Anderson RJ. Osmotic and nonosmotic control of vasopressin release. Am J Physiol Renal Physiol 236: F321-F332, 1979.
28. Szczepanska-Sandowska E. Neuropeptides in neurogenic disorders of the cardiovascular control. J Physiol Pharmacol 57, Suppl 11: 31-53, 2006.
29. Thoren P, Mark AL, Morgan DA, O'Neill TP, Needleman P, Brody MJ. Activation of vagal depressor reflexes by atriopeptins inhibits renal sympathetic nerve activity. Am J Physiol Heart Circ Physiol 251: H1252-H1259, 1986.
30. Uhlich E, Weber P, Eigler J, Gröschel-Stewart U. Angiotensin stimulated AVP release in humans. Klin Wochenschr 53: 177-180, 1975.
31. Williams TDM, Walsh KP, Lightman SL, Sutton R. Atrial natriuretic peptide inhibits postural release of renin and vasopressin in humans. Am J Physiol Regul Integr Comp Physiol 255: R368-R372, 1988.
32. Yamada T, Nakao K, Morii N, Itoh H, Shiono S, Sakamoto M, Sugawara A, Seiito Y, Ohno H, Kancis A, Katsuura G, Eigyo MM, Matsushita A, Imura H. Central effect of atrial natriuretic polypeptide on angiotensin II-stimulated vasopressin secretion in conscious rats. Eur J Pharmacol 125: 453-456, 1986.